Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Neoplasms by Histologic Type
×
durvalumab
×
Clear all
Filters
3
NCT05063565
2026-03-02
ROWAN
Boston Scientific Corporation
Phase 2
Active not recruiting
100 enrolled
NCT06463665
2025-09-26
VIRO-25
Genelux Corporation
Phase 2
Recruiting
142 enrolled